Bolger John C's Form 4 filing
Fulgent Genetics, Inc. (FLGT) · filed Mar 3, 2022
- Accession no.
- 0001209191-22-015590
- Filed
- Mar 3, 2022
- Trade date
- Mar 1, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $115.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bolger John CCIK 0001183863 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2022 | Common Stock | MOption exerciseAcquired | +625 | $3.93 | +$2,456.25 | 2,625 | Direct | |
| Mar 1, 2022 | Common Stock | SSaleDisposed | −625 | $61.42F1 | −$38,387.5 | 2,000 | Direct | |
| Mar 1, 2022 | Common Stock | MOption exerciseAcquired | +625 | $5.81 | +$3,631.25 | 2,625 | Direct | |
| Mar 1, 2022 | Common Stock | SSaleDisposed | −625 | $61.40 | −$38,375 | 2,000 | Direct | |
| Mar 1, 2022 | Common Stock | MOption exerciseAcquired | +625 | $15.82 | +$9,887.5 | 2,625 | Direct | |
| Mar 1, 2022 | Common Stock | SSaleDisposed | −625 | $61.27 | −$38,293.75 | 2,000 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2022 | Common Stock | MOption exerciseDisposed | −625 | $0.00 | $0 | 313 | Direct | |
| Mar 1, 2022 | Common Stock | MOption exerciseDisposed | −625 | $0.00 | $0 | 1,563 | Direct | |
| Mar 1, 2022 | Common Stock | MOption exerciseDisposed | −625 | $0.00 | $0 | 2,813 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The shares were sold in multiple transactions at prices ranging from $61.0767 to $61.4400, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Referenced by the price of 1 transaction in Table I.